CyberKnife Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Gynecological Cancers
Purpose Use of stereotactic ablative radiotherapy (SABR) in the treatment of recurrent or metastatic lesions from a primary gynecologic cancer is a relatively new concept. The present study aims to assess the safety, efficacy, and possible toxicity profile of CyberKnife SABR, recurrent or metastatic...
Main Authors: | Tejinder Kataria, Pushpa Naga, Susovan Banerjee, Deepak Gupta, Kushal Narang, Manoj Tayal, Shyam Singh Bisht |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2021-04-01
|
Series: | South Asian Journal of Cancer |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1731576 |
Similar Items
-
Demystifying CyberKnife Stereotactic Body Radiation Therapy for Interventional Radiologists
by: Azzam Khankan, et al.
Published: (2017-07-01) -
Treatment of Residual, Recurrent, or Metastatic Intracranial Hemangiopericytomas With Stereotactic Radiotherapy Using CyberKnife
by: Lichao Huang, et al.
Published: (2021-03-01) -
Clinical outcome of stereotactic ablative radiotherapy with CyberKnife® for lung tumors: A single center experience
by: Yıldız Güney, et al.
Published: (2018-09-01) -
Successful Treatment of Metastatic Brain Tumor by CyberKnife: A Case Report
by: Cheng-Ta Hsieh, et al.
Published: (2010-03-01) -
Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity
by: Liang P, et al.
Published: (2016-11-01)